{"id":"https://openalex.org/W2494986789","doi":"https://doi.org/10.1158/1538-7445.am2016-292","title":"Abstract 292: Integrated analysis of ibrutinib resistance in chronic lymphocytic leukemia","display_name":"Abstract 292: Integrated analysis of ibrutinib resistance in chronic lymphocytic leukemia","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2494986789","doi":"https://doi.org/10.1158/1538-7445.am2016-292","mag":"2494986789"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-292","doi":"https://doi.org/10.1158/1538-7445.am2016-292","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-292","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055037645","display_name":"Inhye E. Ahn","orcid":"https://orcid.org/0000-0003-3717-287X","observed_orcids":["https://orcid.org/0000-0003-3717-287X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Inhye E. Ahn","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071714714","display_name":"Adam Albitar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153280","display_name":"NeoGenomics (United States)","ror":"https://ror.org/04vj14y69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153280"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Albitar","raw_affiliation_strings":["2NeoGenomics Laboratories, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2NeoGenomics Laboratories, Irvine, CA","institution_ids":["https://openalex.org/I4210153280"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042919966","display_name":"Chingiz Underbayev","orcid":"https://orcid.org/0000-0003-1566-7337","observed_orcids":["https://orcid.org/0000-0003-1566-7337"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chingiz Underbayev","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066494072","display_name":"Sarah E. M. Herman","orcid":"https://orcid.org/0000-0002-3044-9840","observed_orcids":["https://orcid.org/0000-0002-3044-9840"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Herman","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051959420","display_name":"Xin Tian","orcid":"https://orcid.org/0000-0003-1896-2462","observed_orcids":["https://orcid.org/0000-0003-1896-2462"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Tian","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050525368","display_name":"Susan Soto","orcid":"https://orcid.org/0009-0003-3746-890X","observed_orcids":["https://orcid.org/0009-0003-3746-890X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Soto","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065696086","display_name":"Maryalice Stetler\u2010Stevenson","orcid":"https://orcid.org/0000-0003-2591-0353","observed_orcids":["https://orcid.org/0000-0003-2591-0353"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryalice Stetler-Stevenson","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108491565","display_name":"Irina Mari\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irina Maric","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104858244","display_name":"Mohammed Z. H. Farooqui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammed Z. Farooqui","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027800341","display_name":"Maher X. Albitar","orcid":"https://orcid.org/0000-0002-0050-2030","observed_orcids":["https://orcid.org/0000-0002-0050-2030","https://orcid.org/0000-0001-7661-9537"]},"institutions":[{"id":"https://openalex.org/I4210153280","display_name":"NeoGenomics (United States)","ror":"https://ror.org/04vj14y69","country_code":"US","type":"company","lineage":["https://openalex.org/I4210153280"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maher Albitar","raw_affiliation_strings":["2NeoGenomics Laboratories, Irvine, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2NeoGenomics Laboratories, Irvine, CA","institution_ids":["https://openalex.org/I4210153280"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030524385","display_name":"Adrian U. Wiestner","orcid":"https://orcid.org/0000-0002-3533-2924","observed_orcids":["https://orcid.org/0000-0002-3533-2924"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adrian Wiestner","raw_affiliation_strings":["1National Institutes of Health, Bethesda, MD;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1National Institutes of Health, Bethesda, MD;","institution_ids":["https://openalex.org/I1299303238"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"292","last_page":"292"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib-resistance","display_name":"ibrutinib resistance","score":0.9629999995231628},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase","display_name":"Bruton's tyrosine kinase","score":0.9300000071525574},{"id":"https://openalex.org/keywords/plcg2-mutations","display_name":"PLCG2 mutations","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tp53-aberrations","display_name":"TP53 aberrations","score":0.7990000247955322},{"id":"https://openalex.org/keywords/histological-transformation","display_name":"histologic transformation","score":0.6759999990463257},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7860000133514404},{"id":"https://openalex.org/keywords/pi3k-inhibitors","display_name":"PI3K inhibitors","score":0.6209999918937683},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9819999933242798},{"id":"https://openalex.org/keywords/ighv-mutation","display_name":"IGHV mutation","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.9713992476463318},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.7923679351806641},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.7789215445518494},{"id":"https://openalex.org/C2777609679","wikidata":"https://www.wikidata.org/wiki/Q5971015","display_name":"IGHV@","level":4,"score":0.6982157230377197},{"id":"https://openalex.org/C43907098","wikidata":"https://www.wikidata.org/wiki/Q903924","display_name":"breakpoint cluster region","level":3,"score":0.49846720695495605},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46031707525253296},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4305551052093506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4230385422706604},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.41791558265686035},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37568163871765137},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35746413469314575},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.3457437753677368},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3403931260108948},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.14687764644622803}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-292","doi":"https://doi.org/10.1158/1538-7445.am2016-292","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-292","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.7799999713897705}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2518990089","https://openalex.org/W4393090864","https://openalex.org/W4417007910","https://openalex.org/W2983560723","https://openalex.org/W3096173394","https://openalex.org/W2954828829","https://openalex.org/W2979380641","https://openalex.org/W4380577673","https://openalex.org/W4399954718","https://openalex.org/W2983703599"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND:":[1],"Ibrutinib":[2],"covalently":[3],"binds":[4],"to":[5,30,149,163,208,307,372,450],"Bruton's":[6],"tyrosine":[7],"kinase,":[8],"inhibits":[9],"B-cell":[10],"receptor":[11],"signaling,":[12],"and":[13,47,99,107,181,204,225,236,262,271,332,346,359,398,404],"is":[14],"active":[15],"in":[16,168,245,258,263,276,289,355,485],"chronic":[17,486],"lymphocytic":[18,487],"leukemia":[19],"(CLL).":[20],"Progressive":[21],"disease":[22,183],"(PD)":[23],"on":[24,55,377,387],"ibrutinib":[25,56,85,388,435,483],"has":[26],"been":[27],"reported":[28],"due":[29,148,162],"histologic":[31,150],"transformation":[32,261],"or":[33,37,76,79,202,406],"mutations":[34,96,114,218,230,273,328,395,410,423],"of":[35,44,50,97,128,137,141,154,216,228,248,279,327,352,396,408,482,492,497],"BTK":[36,98,220,270,390,397],"PLCG2.":[38],"Here":[39],"we":[40],"report":[41],"integrated":[42],"analysis":[43,481],"the":[45,90,308,493,498],"clinical":[46,285,417,426,437,441],"molecular":[48],"characteristics":[49],"CLL":[51,69,193,345,386],"pts":[52,70,112,130,190,250,259,281,294,383,428,445],"who":[53],"progressed":[54,131],"(PD":[57],"group).":[58],"METHODS:":[59],"Under":[60],"a":[61,102,133],"phase":[62],"II":[63],"investigator-initiated":[64],"trial":[65],"(ClinicalTrials.gov,":[66],"NCT01500733)":[67],"84":[68,129],"with":[71,84,113,170,191,197,260,266,343,384,421,434,443],"TP53":[72,77,171],"aberration":[73],"(deletion":[74],"17p":[75],"mutation)":[78],"age":[80],"\u226565":[81],"were":[82,93,122,147,161,194,206,243,274,287],"treated":[83,196],"420mg":[86],"daily.":[87],"Samples":[88],"from":[89,119,292,374,431],"PD":[91,286,342],"group":[92],"tested":[94],"for":[95,186,501],"PLCG2":[100,232,272,392,399],"by":[101,324,370],"high-sensitivity":[103],"assay":[104],"using":[105],"branched":[106],"locked":[108],"nucleic":[109],"acids.":[110],"In":[111,419],"at":[115,132,219,231,338,402],"PD,":[116,366],"stored":[117,290],"samples":[118,291],"earlier":[120],"time-points":[121],"also":[123],"sequenced.":[124],"RESULTS:":[125],"13":[126,298],"(15.5%)":[127],"median":[134,305],"follow":[135],"up":[136],"24":[138,237],"months.":[139],"3":[140],"4":[142],"early":[143,296],"PDs":[144,157],"(\u226412":[145],"months)":[146,160],"transformation,":[151],"while":[152],"8":[153,189,246,280],"9":[155,249],"late":[156],"(median":[158],"34.9":[159],"CLL.":[164,253,268],"PFS":[165],"was":[166,256,312],"inferior":[167],"subgroups":[169],"aberration,":[172],"unmutated":[173],"IGHV,":[174],"advanced":[175],"Rai":[176],"stage,":[177],"high":[178],"\u03b2-2":[179],"microglobulin":[180],"relapsed/refractory":[182],"(log-rank":[184],"p<0.05":[185],"all":[187],"tests).":[188],"progressive":[192,252,267,344,385],"subsequently":[195],"small":[198],"molecules":[199],"targeting":[200],"PI3K":[201],"Bcl-2,":[203],"6":[205,293],"alive":[207],"date":[209],"(longest":[210],"follow-up":[211],"15":[212,222],"months).":[213],"Two":[214],"types":[215,227,326],"non-synonymous":[217,229],"exon":[221,233],"(C481S,":[223],"C481R)":[224],"five":[226],"19,":[234],"20":[235],"(R665W,":[238],"P664S,":[239],"P664L,":[240],"S707Y,":[241],"L845F)":[242],"identified":[244,288],"out":[247,278],"having":[251],"No":[254],"mutation":[255,311],"found":[257,275],"one":[264],"pt":[265],"Concomitant":[269],"5":[277],"(62.5%).":[282],"Mutations":[283],"pre-dating":[284],"as":[295,297,322],"months":[299,314,415],"before":[300,416],"progression":[301,438,442],"(range":[302,315],"1.8-13.0).":[303],"The":[304],"time":[306,321],"first":[309],"detected":[310],"23.1":[313],"5.4-34.7).":[316],"Mutational":[317],"complexity":[318],"increased":[319,369],"over":[320],"reflected":[323],"increasing":[325],"(n":[329,335],"=":[330,336],"3)":[331,337],"allele":[333],"frequencies":[334],"later":[339],"time-points.":[340],"Both":[341],"non-PD":[347],"groups":[348],"showed":[349],"equivalent":[350],"depth":[351],"best":[353],"response":[354],"peripheral":[356],"blood":[357],"(PB)":[358],"bone":[360],"marrow":[361],"during":[362],"treatment":[363,433],"(p>0.05).":[364],"At":[365],"tumor":[367],"burden":[368],"2":[371],"32-fold":[373],"nadir":[375],"based":[376],"PB":[378],"flow":[379],"cytometry.":[380],"CONCLUSION:":[381],"Most":[382],"carry":[389],"and/or":[391],"mutations.":[393],"Concurrent":[394],"are":[400],"common":[401],"progression,":[403,427],"either":[405],"both":[407],"these":[409],"can":[411,429,446],"be":[412],"acquired":[413],"many":[414],"progression.":[418],"cases":[420],"detectable":[422],"but":[424],"without":[425],"benefit":[430],"prolonged":[432],"until":[436],"occurs.":[439],"Upon":[440],"CLL,":[444],"still":[447],"show":[448],"responses":[449],"alternative":[451],"targeted":[452],"agents.":[453],"Citation":[454],"Format:":[455],"Inhye":[456],"E.":[457],"Ahn,":[458],"Adam":[459],"Albitar,":[460,477],"Chingiz":[461],"Underbayev,":[462],"Sarah":[463],"Herman,":[464],"Xin":[465],"Tian,":[466],"Susan":[467],"Soto,":[468],"Maryalice":[469],"Stetler-Stevenson,":[470],"Irina":[471],"Maric,":[472],"Mohammed":[473],"Z.":[474],"Farooqui,":[475],"Maher":[476],"Adrian":[478],"Wiestner.":[479],"Integrated":[480],"resistance":[484],"leukemia.":[488],"[abstract].":[489],"In:":[490],"Proceedings":[491],"107th":[494],"Annual":[495],"Meeting":[496],"American":[499],"Association":[500],"Cancer":[502,513],"Research;":[503],"2016":[504],"Apr":[505],"16-20;":[506],"New":[507],"Orleans,":[508],"LA.":[509],"Philadelphia":[510],"(PA):":[511],"AACR;":[512],"Res":[514],"2016;76(14":[515],"Suppl):Abstract":[516],"nr":[517],"292.":[518]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-08-23T00:00:00"}